This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
2C-D: Difference between revisions
>Josikins No edit summary |
>Josikins No edit summary |
||
| Line 1: | Line 1: | ||
{{proofread}} | |||
{{SubstanceBox/2C-D}} | {{SubstanceBox/2C-D}} | ||
'''2C-D''' ('''2,5-dimethoxy-4-methylphenethylamine''', also known as '''2C-M''') is a [[psychedelic]] drug of the [[2C-x]] family that is sometimes used as an [[entheogen]]. It was first synthesized in 1970 by a team from the Texas Research Institute of Mental Sciences,<ref>https://www.ncbi.nlm.nih.gov/pubmed/5412084</ref> and its activity was subsequently investigated in humans by [[Alexander Shulgin]]<ref>Alexander Shulgin - PIHKAL | http://www.erowid.org/library/books_online/pihkal/pihkal033.shtml</ref>. The full name of the chemical is '''2,5-dimethoxy-4-methylphenethylamine'''. In his book PiHKAL (Phenethylamines i Have Known And Loved), Shulgin lists the dosage range as being from 20 to 60 mg and many people recommend higher doses. Lower doses (generally 10 mg or less) of 2C-D have been explored as a potential nootropic, albeit with mixed results. 2C-D is generally taken orally, though may be insufflated (i.e., taken nasally). Insufflating tends to cause intense pain, however, and the dosage level is usually much lower, typically in the region of 1 to 15 mg. | '''2C-D''' ('''2,5-dimethoxy-4-methylphenethylamine''', also known as '''2C-M''') is a [[psychedelic]] drug of the [[2C-x]] family that is sometimes used as an [[entheogen]]. It was first synthesized in 1970 by a team from the Texas Research Institute of Mental Sciences,<ref>https://www.ncbi.nlm.nih.gov/pubmed/5412084</ref> and its activity was subsequently investigated in humans by [[Alexander Shulgin]]<ref>Alexander Shulgin - PIHKAL | http://www.erowid.org/library/books_online/pihkal/pihkal033.shtml</ref>. The full name of the chemical is '''2,5-dimethoxy-4-methylphenethylamine'''. In his book PiHKAL (Phenethylamines i Have Known And Loved), Shulgin lists the dosage range as being from 20 to 60 mg and many people recommend higher doses. Lower doses (generally 10 mg or less) of 2C-D have been explored as a potential nootropic, albeit with mixed results. 2C-D is generally taken orally, though may be insufflated (i.e., taken nasally). Insufflating tends to cause intense pain, however, and the dosage level is usually much lower, typically in the region of 1 to 15 mg. | ||
| Line 64: | Line 58: | ||
====Distortions==== | ====Distortions==== | ||
2C-D presents a full and complete array of possible visual distortions which generally includes: | 2C-D presents a full and complete array of possible visual distortions which generally includes: | ||
*'''[[Effect::Drifting]]''' ''([[Drifting#Melting|melting]], [[Drifting#Flowing|flowing]], [[Drifting#Breathing|breathing]] and [[Drifting#morphing|morphing]])'' - In comparison to other psychedelics, this effect can be described as | *'''[[Effect::Drifting]]''' ''([[Drifting#Melting|melting]], [[Drifting#Flowing|flowing]], [[Drifting#Breathing|breathing]] and [[Drifting#morphing|morphing]])'' - In comparison to other psychedelics, this effect can be described as low in detail, slow and smooth in motion, static in appearance and realistic in style. | ||
*'''[[Effect::Tracers]]''' | *'''[[Effect::Tracers]]''' | ||
*'''[[Effect::Colour shifting]]''' | *'''[[Effect::Colour shifting]]''' | ||
| Line 75: | Line 69: | ||
*'''[[Effect::Transformations]]''' | *'''[[Effect::Transformations]]''' | ||
*'''[[Effect::Internal hallucinations]]''' (''[[effect::autonomous entities]]''; ''[[effect::settings, sceneries, and landscapes]]''; ''[[effect::alterations in perspective]]'' and ''[[effect::scenarios and plots]]'') - In comparison to other psychedelics such as [[LSD]], 2C-D is | *'''[[Effect::Internal hallucinations]]''' (''[[effect::autonomous entities]]''; ''[[effect::settings, sceneries, and landscapes]]''; ''[[effect::alterations in perspective]]'' and ''[[effect::scenarios and plots]]'') - In comparison to other psychedelics such as [[LSD]], 2C-D is low in hallucinations embedded within visual geometry. However, when it does occur this particular effect commonly contains hallucinations with scenarios, settings, concepts and autonomous entity contact. They are more common within dark environments and can be described as internal in their manifestation, lucid in believability, and interactive in style. | ||
*'''[[Effect::External hallucinations]]''' (''[[effect::autonomous entities]]''; ''[[effect::settings, sceneries, and landscapes]]''; ''[[effect::alterations in perspective]]'' and ''[[effect::scenarios and plots]]'') - 2C-D is capable of external hallucinations embedded within visual geometry. This particular effect commonly contains hallucinations with scenarios, settings, concepts and autonomous entity contact. They can be described as external in their manifestation, lucid in believability, and | *'''[[Effect::External hallucinations]]''' (''[[effect::autonomous entities]]''; ''[[effect::settings, sceneries, and landscapes]]''; ''[[effect::alterations in perspective]]'' and ''[[effect::scenarios and plots]]'') - 2C-D is capable of external hallucinations embedded within visual geometry. This particular effect commonly contains hallucinations with scenarios, settings, concepts and autonomous entity contact. They can be described as external in their manifestation, lucid in believability, and fixed in style. | ||
===Auditory effects=== | ===Auditory effects=== | ||